| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |